StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Nuo Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Nuo Therapeutics's price to book ratio was 145.1× on Apr 30, 2025, against 34.1× a year earlier. Over the last 4 years it ranged from 0.0× to 145.1×, with a median of 42.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 2025145.1×+71.8
2024Dec 31, 202473.3×+41.2
2023Dec 29, 202332.0×+12.1
2022Dec 30, 202219.9×+9.1
2018Apr 30, 201810.8×+10.5
2017Dec 29, 20170.3×–

More Nuo Therapeutics figures

See a number that looks wrong?